BridgeMD
New treatment option for Alzheimer Disease
Official title Transcranial Pulse Stimulation. a Potential Treatment for Early Dementia
ClinicalTrials.gov ID: NCT06730438
What this study is testing
- What it's testing
- Alzheimer's Disease (AD) is characterized by the absence of treatments to slow, stop, or reverse its course, with patients finally losing cognitive functions, skills and independence. It is a chronic degenerative disease with high social and medical burden worldwide: AD ranked third among neurological disorders in terms of disability-adjusted life years (DALY) rates.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- age\>18 years
- diagnosis of early dementia according to current international guidelines
- disease duration of at least 12 months
- consent to participate in the study.
You likely can't join if
- medical instability interfering with standard neurological assessment
- any contraindication to preliminary MRI for MR-based real-time neuronavigation
- comorbidities which may interfere with cognitive status
- any contraindication to Transcranial Pulse Stimulation.
The study team makes the final eligibility decision.
Where it's taking place
- L’Aquila, Italy, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include L’Aquila, Italy, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.